98 related articles for article (PubMed ID: 1838231)
1. Amplification of T cell activation induced by CD73 (ecto-5' nucleotidase) engagement.
Massaia M; Attisano C; Redoglia V; Bianchi A; Thompson LF; Dianzani U; Pileri A
Adv Exp Med Biol; 1991; 309B():155-8. PubMed ID: 1838231
[No Abstract] [Full Text] [Related]
2. Decreased number of CD73 (ecto-5'-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro.
Christensen LD; Andersen V; Ryder L
Scand J Immunol; 1996 Jul; 44(1):62-70. PubMed ID: 8693293
[TBL] [Abstract][Full Text] [Related]
3. Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.
Gutensohn W; Resta R; Misumi Y; Ikehara Y; Thompson LF
Cell Immunol; 1995 Apr; 161(2):213-7. PubMed ID: 7697732
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).
Thomson LF; Ruedi JM; Glass A; Moldenhauer G; Moller P; Low MG; Klemens MR; Massaia M; Lucas AH
Tissue Antigens; 1990 Jan; 35(1):9-19. PubMed ID: 2137649
[TBL] [Abstract][Full Text] [Related]
5. CD73 (ecto-5'-nucleotidase) on blood mononuclear cells. Regulation of ecto-5'-nucleotidase activity and antigenic heterogeneity of CD73 on blood mononuclear cells from healthy donors and from patients with immunodeficiency.
Christensen LD
APMIS Suppl; 1997; 73():1-28. PubMed ID: 9393563
[No Abstract] [Full Text] [Related]
6. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature.
Yegutkin GG; Auvinen K; Rantakari P; Hollmén M; Karikoski M; Grénman R; Elima K; Jalkanen S; Salmi M
Eur J Immunol; 2015 Feb; 45(2):562-73. PubMed ID: 25402681
[TBL] [Abstract][Full Text] [Related]
7. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
[TBL] [Abstract][Full Text] [Related]
8. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.
Airas L; Niemelä J; Jalkanen S
J Immunol; 2000 Nov; 165(10):5411-7. PubMed ID: 11067892
[TBL] [Abstract][Full Text] [Related]
9. HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.
Carrière M; Lacabaratz C; Kök A; Benne C; Jenabian MA; Casartelli N; Hüe S; Hocqueloux L; Lelièvre JD; Lévy Y
J Infect Dis; 2014 May; 209(9):1321-30. PubMed ID: 24357632
[TBL] [Abstract][Full Text] [Related]
10. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
[TBL] [Abstract][Full Text] [Related]
11. Different role of CD73 in leukocyte trafficking via blood and lymph vessels.
Ålgars A; Karikoski M; Yegutkin GG; Stoitzner P; Niemelä J; Salmi M; Jalkanen S
Blood; 2011 Apr; 117(16):4387-93. PubMed ID: 21346249
[TBL] [Abstract][Full Text] [Related]
12. CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve.
Meyer Zu Hörste G; Reiners J; Lehmann HC; Airas L; Kieseier BC
Muscle Nerve; 2009 Aug; 40(2):287-9. PubMed ID: 19609917
[TBL] [Abstract][Full Text] [Related]
13. CD73 expression and fyn-dependent signaling on murine lymphocytes.
Yamashita Y; Hooker SW; Jiang H; Laurent AB; Resta R; Khare K; Coe A; Kincade PW; Thompson LF
Eur J Immunol; 1998 Oct; 28(10):2981-90. PubMed ID: 9808167
[TBL] [Abstract][Full Text] [Related]
14. Increased density of ecto 5' nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Fukunaga Y; Evans SS; Yamamoto M; Ueda Y; Tamura K; Takakuwa T; Gebhard D; Allopenna J; Demaria S; Clarkson B
Blood; 1989 Nov; 74(7):2486-92. PubMed ID: 2553165
[TBL] [Abstract][Full Text] [Related]
15. CD73: a novel target for cancer immunotherapy.
Zhang B
Cancer Res; 2010 Aug; 70(16):6407-11. PubMed ID: 20682793
[TBL] [Abstract][Full Text] [Related]
16. Glycosyl phosphatidylinositol membrane anchor is not required for T cell activation through CD73.
Resta R; Hooker SW; Laurent AB; Shuck JK; Misumi Y; Ikehara Y; Koretzky GA; Thompson LF
J Immunol; 1994 Aug; 153(3):1046-53. PubMed ID: 8027539
[TBL] [Abstract][Full Text] [Related]
17. Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure.
Quast C; Alter C; Ding Z; Borg N; Schrader J
Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28404626
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization of ecto-5'-nucleotidase-positive and -negative human T lymphocytes.
Thompson LF; Ruedi JM
J Immunol; 1989 Mar; 142(5):1518-22. PubMed ID: 2537356
[TBL] [Abstract][Full Text] [Related]
19. Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.
Krüger KH; Thompson LF; Kaufmann M; Möller P
Br J Cancer; 1991 Jan; 63(1):114-8. PubMed ID: 1989648
[TBL] [Abstract][Full Text] [Related]
20. Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes.
Dianzani U; Redoglia V; Bragardo M; Attisano C; Bianchi A; Di Franco D; Ramenghi U; Wolff H; Thompson LF; Pileri A
J Immunol; 1993 Oct; 151(8):3961-70. PubMed ID: 7691935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
